Skip to main content
Equibles

Affinity Asset Advisors, LLC

Position in RZLT — Rezolute, Inc.

CIK 1773195 NEW YORK, NY
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,200,000
+$479,695 QoQ
Shares Held
1,000,000
-35.4% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#20
of 144 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. RZLT ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 3,750,000 $132,712,500
2 APGE
Apogee Therapeutics, Inc.
 987,000 $131,004,510
3 SYRE
Spyre Therapeutics, Inc.
 1,279,134 $113,561,516
4 XENE
Xenon Pharmaceuticals Inc.
 1,595,000 $96,274,200
5 ERAS
Erasca, Inc.
 5,250,000 $96,180,000
6 INSM
INSMED Inc
 650,000 $69,303,000
7 PRAX
Praxis Precision Medicines, Inc.
 185,000 $61,936,150
8 ORKA
Oruka Therapeutics, Inc.
 590,000 $56,150,300

All Filings in RZLT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,200,000 1,000,000
2026-03-31 $4,720,305 1,547,641
2025-12-31 $5,548,699 2,351,144
2025-09-30 $19,740,000 2,100,000
2025-06-30 $9,812,000 2,200,000
2025-03-31 $4,930,000 1,700,000
2024-12-31 $7,717,500 1,575,000
2024-09-30 $8,245,000 1,700,000
2024-06-30 $7,955,000 1,850,000
2024-03-31 $4,080,000 1,600,000